This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
Description, Dosage, Side Effects, Contraindications. Data from EMA, URPL, openFDA and other regulatory sources.
| Apixaban | Rivaroxaban | |
|---|---|---|
| Active Substances | APIXABAN | RIVAROXABAN |
| ATC Code | B01AF02 | B01AF01 |
| Form | TABLET | — |
| Dosage | 2.5MG | — |
| Route | ORAL | — |
| Manufacturer | REGCON HOLDINGS LLC | ACCORD HEALTHCARE INC |
| Indications | This medication is an anticoagulant, which is used for reducing the risk of strokes and blood clots in patients with atrial fibrillation who have no problems with their heart valve (nonvalvular atrial fibrillation). | — |
| Side Effects | The most common side effect is bleeding. Other side effects include bleeding in the stomach, intestines, brain, and eyes; the bleeding may be fatal. | — |
| Warnings | • Caution should be exercised in patients with history of kidney or liver problems, bleeding problems, any allergy, who are taking other medications, children, during pregnancy and breastfeeding. • Patients already taking 2.5 mg BID, avoid coadministration with strong dual inhibitors. • Discontinuing eliquis in patients without adequate continuous anticoagulation increases risk of stroke. | — |
Apixaban (INN: APIXABAN, ATC B01AF02) and Rivaroxaban (INN: RIVAROXABAN, ATC B01AF01) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.